PDR delivers critical drug information and resources trusted and relied on by prescribers for generations. Drug Labels Continuously updated prescribing information from the PDR ®

U.S.-based MDs, DOs, NPs and PAs in full-time patient practice can register for free access to the Prescribers’ Digital Reference on PDR.net. PDR.net is to be used only as a reference aid, it is …

FDA approved earlier in 2024 as the first nonsteroidal drug for the treatment of patients with all genetic variants of DMD, the small molecule is supplied as an oral suspension that contains …

Overall, the trials determined the successful efficacy of the drug and confirmed its potential for broad application for combating complex bacterial infection in various populations. A new …

Get more information on PDR's monthly Drug Updates, including the latest in FDA news and drug labeling updates.

PDR FDA Drug Safety Communications provide the public with easy access to the most important important drug safety information from the FDA

The Related Drug Information Index provides comprehensive access to all drug information related to a specific drug Types of content include full prescribing information, drug …

The Related Drug Information Index provides comprehensive access to all drug information related to a specific drug Types of content include full prescribing information, drug …

The FDA has approved the supplemental new drug application for Vemlidy (tenofovir alafenamide) 25mg tablets as a once-daily treatment for chronic hepatitis B virus infection in …

The initial approval and continued study and review of Ixchiq are important advancements in work devoted to changing the approach to a potentially debilitating disease with limited treatment …